Related Experiment Video
Updated: Sep 11, 2025

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
SLFN11-mediated tRNA regulation induces cell death by disrupting proteostasis in response to DNA-damaging agents
Yuki Iimori1,2, Teppei Morita1,2,3, Takeshi Masuda1,2
1Institute for Advanced Biosciences, Keio University, Tsuruoka 997-0017, Japan.
Abstract:
DNA-damaging agents (DDAs) have long been used in cancer therapy. However, the mechanisms by which DDAs induce cell death are not fully understood, and drug resistance remains a major clinical challenge. Schlafen 11 (SLFN11) was identified as the gene most strongly correlated with sensitivity to DDAs based on mRNA expression levels. SLFN11 sensitizes cancer cells to DDAs by cleaving and decreasing tRNALeu(TAA) levels. Elucidating the detailed mechanism by which SLFN11 induces cell death is expected to provide insights into overcoming drug resistance. Here, we show that, upon administration of DDAs, SLFN11 cleaves tRNALeu(TAA), triggering ER stress and protein aggregate formation, leading to cell death regulated by inositol-requiring enzyme 1 alpha (IRE1α). These responses were significantly alleviated by SLFN11-knockout or transfection of tRNALeu(TAA). Proteomic analysis suggests tRNALeu(TAA) influences proteins essential for maintaining proteostasis, especially those involved in ubiquitin-dependent proteolysis. Additionally, we identified the cleavage sites of tRNALeu(TAA) generated by SLFN11 in cells and revealed that tRNA fragments contribute to ER stress and cell death. These findings suggest that SLFN11 plays a crucial role in proteostasis by regulating tRNAs and thus determines cell fate under DDA treatment. Consequently, targeting SLFN11-mediated tRNA regulation could offer a novel approach to improve cancer therapy.
Insights
Schlafen 11 (SLFN11) sensitizes cancer cells to DNA-damaging agents (DDAs) by cleaving tRNALeu(TAA), causing ER stress and cell death. Targeting this SLFN11-tRNA pathway offers a new strategy to overcome cancer drug resistance.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Stress Response
Background:
- DNA-damaging agents (DDAs) are vital cancer therapeutics, but their precise cell death mechanisms and acquired drug resistance are significant clinical hurdles.
- Schlafen 11 (SLFN11) gene expression strongly correlates with DDA sensitivity, indicating its critical role in treatment response.
- SLFN11 sensitizes cancer cells to DDAs by reducing tRNALeu(TAA) levels, but the downstream effects remain incompletely understood.
Purpose of the Study:
- To elucidate the detailed molecular mechanism by which SLFN11 induces cell death upon DDA treatment.
- To investigate the role of tRNALeu(TAA) cleavage and subsequent cellular events in DDA-induced cytotoxicity.
- To explore the potential of targeting the SLFN11-tRNA axis for novel cancer therapy strategies.
Main Methods:
- Administration of DDAs to cancer cells with varying SLFN11 expression levels.
- Analysis of tRNALeu(TAA) levels, endoplasmic reticulum (ER) stress markers, and protein aggregation.
- Utilizing SLFN11-knockout and tRNALeu(TAA)-transfected cells to assess functional impact.
- Proteomic analysis to identify proteins affected by tRNALeu(TAA) levels.
- Identification of specific tRNA cleavage sites generated by SLFN11.
Main Results:
- SLFN11-mediated cleavage of tRNALeu(TAA) upon DDA treatment triggers significant ER stress and protein aggregate formation.
- Inositol-requiring enzyme 1 alpha (IRE1α) pathway is involved in regulating DDA-induced cell death mediated by SLFN11.
- SLFN11-knockout or tRNALeu(TAA) re-expression substantially alleviated DDA-induced stress and cell death.
- Proteomic data indicate tRNALeu(TAA) influences proteostasis, particularly ubiquitin-dependent proteolysis.
- Specific tRNA fragments resulting from SLFN11 cleavage were identified and shown to contribute to ER stress and cell death.
Conclusions:
- SLFN11 critically regulates proteostasis by controlling tRNALeu(TAA) levels, thereby determining cancer cell fate under DDA stress.
- The SLFN11-tRNA-ER stress-IRE1α axis represents a key mechanism of DDA-induced cell death.
- Targeting SLFN11 and its regulation of tRNA offers a promising therapeutic avenue to enhance DDA efficacy and overcome drug resistance in cancer treatment.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Regulation of the Unfolded Protein Response
Replicative Cell Senescence
Overview of DNA Repair
Chemically...
DNA Damage Can Stall the Cell Cycle
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...

